Literature DB >> 1973162

Growth, feed efficiency and carcass composition of finishing Friesian steers fed the beta-adrenergic agonist L-644,969.

A P Moloney1, P Allen, D B Ross, G Olson, E M Convey.   

Abstract

The beta-adrenergic agonist L-644,969 was evaluated to determine its effects on growth performance and carcass composition of Friesian steers. L-644,969 is the R,R isomer of 6-amino [[(1-methyl-3-phenylpropyl) amino] methyl]-3-pyridine methanol dihydrochloride. Four groups of 18 steers, averaging 380 kg body weight, were individually given ad libitum access to a pelleted concentrate diet that contained either 0, .25, 1.0 or 4.0 ppm L-644,969 for the final 12 wk of the finishing period. Live weight gain was not affected by L-644,969, but feed consumption was linearly reduced (5.5, 6.3 and 15.7%; P less than .01) and feed conversion efficiency was linearly increased (16, 25 and 31%; P less than .01) relative to unmedicated controls, respectively. In addition, L-644,969 quadratically increased carcass weight (3.7, 9.3 and 8.5%; P less than .01) and dressing percentage (2.7, 7.9 and 7.9%; P less than .001). The proportion of trimmed fat in the carcass was quadratically reduced (14.5, 29 and 36%; P less than .001) and yield of lean meat quadratically increased (6.7, 13 and 15.6%; P less than .001). beta-adrenergic agonist treatment altered the distribution of lean meat such that a greater (P less than .001) proportion of the total lean was in the hind portion of carcasses from treated animals. Based on these findings, we suggest that L-644,969 may have utility as an agent to improve efficiency of production of lean beef.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973162     DOI: 10.2527/1990.6851269x

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  3 in total

Review 1.  Physiological parameter values for physiologically based pharmacokinetic models in food-producing animals. Part I: Cattle and swine.

Authors:  Zhoumeng Lin; Miao Li; Yu-Shin Wang; Lisa A Tell; Ronald E Baynes; Jennifer L Davis; Thomas W Vickroy; Jim E Riviere
Journal:  J Vet Pharmacol Ther       Date:  2020-04-08       Impact factor: 1.786

2.  Lubabegron fumarate acts as a β-adrenergic receptor antagonist in cultured bovine intramuscular and subcutaneous adipocytes.

Authors:  Jinhee H Hwang; John C Kube; Stephen B Smith
Journal:  J Anim Sci       Date:  2022-03-01       Impact factor: 3.338

3.  Characterization of β-adrenergic receptors in bovine intramuscular and subcutaneous adipose tissue: comparison of lubabegron fumarate with β-adrenergic receptor agonists and antagonists.

Authors:  Jinhee H Hwang; Michael E Spurlock; John C Kube; Xiang Z Li; Stephen B Smith
Journal:  J Anim Sci       Date:  2021-08-01       Impact factor: 3.159

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.